Molnupirvir-induced SARS-CoV-2 mutagenesis mechanism and results of this antiviral in patients affected by COVID-19. Research, Society and Development, [S. l.], v. 10, n. 15, p. e231101522916, 2021. DOI: 10.33448/rsd-v10i15.22916. Disponível em: https://rsdjournal.org/rsd/article/view/22916. Acesso em: 5 dec. 2025.